The Modified Ashworth Scale is a widely used clinical tool to measure spasticity in patients with neurological disorders. The word "Modified Ashworth Scale" is spelled as /’mɒdɪfaɪd ˈæʃwɜːθ skeɪl/ in IPA phonetic transcription. The first syllable "mod" is pronounced as /mɒd/ with a short "o" sound. The second syllable "i" is pronounced as /ɪ/ with a short "i" sound. "Fied" in the word "modified" is pronounced as /faɪd/. "Ashworth" is pronounced as /’æʃwɜːθ/ with a silent "h". Lastly, "scale" is pronounced as /skeɪl/ with a long "a" sound.
The Modified Ashworth Scale (MAS) is a commonly used clinical assessment tool used to measure spasticity in patients with neurological conditions such as stroke, cerebral palsy, or multiple sclerosis. It is designed to evaluate the resistance encountered during passive movement of a limb.
The scale consists of six levels ranging from 0 to 4, reflecting increasing degrees of spasticity. Level 0 indicates no increase in muscle tone, while level 4 represents the highest degree of resistance, with the affected limb rigid in flexion or extension. Each level is characterized by the examiner's perception of resistance during passive movement, which may vary depending on the velocity and direction of the movement.
During the assessment, the examiner manually moves each joint in the specific limb being evaluated, at a controlled speed, while observing the response of the patient's muscles. The MAS helps to provide an objective measurement of spasticity, allowing for a more accurate assessment and monitoring of treatment outcomes over time.
Although the MAS is widely used, it is important to note that it has some limitations. It primarily focuses on muscle tone and resistance, while other aspects of spasticity such as clonus and contractures are not assessed. Additionally, the scale relies on the subjective judgment of the examiner, which may introduce variability between different assessors. Despite these limitations, the Modified Ashworth Scale remains a valuable tool in clinical practice for assessing and monitoring spasticity in neurological conditions.